Recombinant Human ICAM2 Protein，His

ICAM-2 (Intercellular Adhesion Molecule-2) is a pivotal glycoprotein that plays a crucial role in the immune response by facilitating the adhesion of leukocytes to endothelial cells, thereby influencing inflammation and immune regulation. It belongs to the immunoglobulin superfamily and is primarily expressed on endothelial cells, where it interacts with lymphocyte function-associated antigen-1 (LFA-1), a vital receptor on T cells, facilitating their migration to sites of inflammation. Research on recombinant ICAM-2 proteins has gained significance in understanding the molecular mechanisms underlying immune cell trafficking and the pathogenesis of various inflammatory diseases. Moreover, studies involving the recombinant expression of ICAM-2 have shown potential applications in immunotherapy, where it could enhance the efficacy of vaccines or serve as a biomarker for certain diseases. With advances in molecular biology techniques, the ability to produce and characterize ICAM-2 as a recombinant protein has opened new avenues for therapeutic interventions, providing insights into its structure-function relationships and potential therapeutic roles in modulating immune responses. The ongoing research into ICAM-2 is not only essential for unraveling its biological functions but also for developing innovative strategies to target and treat inflammatory conditions and associated disorders.